The main aim of the study described in this thesis is the development of small molecules as inhibitors targeting signal transduction pathways, thereby treating cancer. We attempted to synthesize compounds based on the hits obtained from high throughput screening of the Chemdiv diversity set compounds. Chapter One is a general introduction to cancer, history of chemotherapeutic drugs and an introduction to signal transduction pathways. The following two chapters briefly introduce the biological targets in the authors study. Chapter Two describes the role of B-cell lymphoma type xL (Bcl-xL), in apoptosis and the development of drugs targeting Bcl-xL. Examples of Bcl-xL drugs relevant to this study have been provided. Chapter Three introduces Src homology 2 (SH2) domain containing tyrosine phosphatase Shp2, a protein tyrosine phosphatase, as an oncogene, its role in signal transduction pathways and the recent developments in drug development towards the inhibition of this oncogene. Chapter Four gives a general introduction to microwave-assisted organic synthesis and its advantages. This chapter also describes the use of flow reactors in organic synthesis and its advantages. The following two chapters describe the author's own findings. Chapter Five focuses on the design, synthesis and biological evaluation of small molecules as inhibitors of Bcl-xL. Isoquinolinols, NSC-131734 and HL2-100 emerged as lead compounds from high throughput screening for Bcl-xL. Our strategy focused on identifying an isoquinolinol lead with increased potency. Based on isatin hits obtained earlier through HTS screen and SAR studies in our lab, more isatin derivatives were synthesized focusing on developing inhibitors with increased cell permeability and improved potency.

No description available.

Tuberculosis, caused by the pathogenic bacteria Mycobacterium tuberculosis, is one of the most widespread and deadly infectious diseases today. Treatment of tuberculosis relies on antibiotics that were developed more than 50 years ago. These are now becoming ineffective due to the emergence of antibiotic resistant strains of the bacteria. The aim of the research in this thesis was to develop new antibiotics for tuberculosis treatment. To this end, we targeted enzymes from two essential biosynthetic pathways in M. tuberculosis for drug development. The methylerythritol phosphate (MEP) pathway synthesizes a group of compounds called isoprenoids. These compounds have essential roles in all living organisms. The fact that humans utilize a different pathway for isoprenoid synthesis makes the MEP pathway enzymes attractive targets for drug development. We have determined the structures of two essential enzymes from this pathway by X-ray crystallography: 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) and 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (IspD). These are the first structures of these enzymes from M. tuberculosis. Additionally, structures of the IspD enzyme from the related bacteria Mycobacterium smegmatis were determined. We have characterized these enzymes and evaluated the efficiency of a number of inhibitors of the DXR enzyme by biochemical methods. Crystal structures of DXR in complex with some of these inhibitors were also determined. The second pathway of interest for drug development is the universal pathway for Coenzyme A biosynthesis. Enzymes in this pathway have essential roles in all living organisms. However, the bacterial enzymes have little similarity to the human homologues. We have determined a number of structures of the M. tuberculosis pantothenate kinase (PanK), the regulatory enzyme of this pathway, in complex with two new classes of inhibitory compounds, and evaluated these by biochemical methods. The structures and biochemical characterization of these enzymes provide us with detailed information about their functions and broadens our knowledge of these bacteria. Biochemical and structural information about new inhibitors of these enzymes serve as a starting point for future development of antibiotics against tuberculosis.

Cancer est un terme qui rassemble plusieurs ensembles hétérogène de maladies et il est caractérisé par la perte de contrôle physiologique et la transformation maligne des cellules saines. Il est essentiel de comprendre le cancer de la biologie cellulaire afin d'identifier de nouveaux biomarqueurs pour le diagnostic précoce et la conception de nouvelles stratégies thérapeutiques. Reprogrammation métabolique est une caractéristique émergente de cancer, ce qui signifie que les cellules cancéreuses passent leur métabolisme de base pour répondre aux exigences accrues de la croissance et la division cellulaire. Par conséquent, explorer reprogrammant métabolique que les cellules cancéreuses subissent est une stratégie clé pour identifier de nouvelles cibles pour le traitement du cancer. Dans cette thèse, de nouvelles possibilités pour le traitement du cancer ont été explorés en analysant la reprogrammation métabolique de la tumeur. À cet égard, nous avons étudié et proposé voie des pentoses phosphates (PPP) enzymes cibles thérapeutiques putatifs contre les cancers du sein et du côlon. En outre, nous avons exploré le métabolisme de la glutamine dans les cellules du cancer du sein et les adaptations du réseau métaboliques qu'ils subissent dans le but de contourner la privation de glutamine et la déficience mitochondriale générale. Ainsi, le ciblage PPP est l'intérêt des chercheurs d'utiliser à la fois oxydantes et non oxydantes phases de cette voie métabolique comme une cible de médicament thérapeutique. Pour tester cela, nous inhibés bœuf PPP enzymes 6PGD dans les cellules cancéreuses du sein et G6PD dans les cellules du côlon.Nous avons effectué la caractérisation de la reprogrammation métabolique induite par l'inhibition de l'enzyme de bœuf PPP par l'ARN interferase (ARNi) silençage médiation, afin d'explorer le potentiel de cette enzyme comme une cible de médicament thérapeutique dans deux lignées de cellules de cancer du sein. Nous avons demontré que l'inhibition 6PGD a entraîné une diminution taux de prolifération, arrêt du cycle cellulaire et induction de l'apoptose médiée par l'activation de p53, en diminuant les capacités de formation mammosphere et le métabolisme altéré de carbone central par modulation de Warburg phenomenan et en améliorant le métabolisme de la glutamine. D'autre part, nous avons montré l'effet de l'inhibition de la G6PD sur la prolifération des cellules du cancer du côlon et du PPP est régulée par la disponibilité de la glutamine dans les cellules cancéreuses du côlon.De plus, nous avons caractérisé les adaptations métaboliques que les cellules cancéreuses du sein subissent la privation de glutamine ou lorsque les mitochondries sont fait défection. Nous avons effectué une analyse des flux métaboliques utilisant métabolomique et Fluxomique et nous avons utilisé la biologie des systèmes afin d'estimer une vision globale des modifications de flux dans différentes conditions de culture. Nous avons observé une augmentation du cycle de pyruvate avec privation glutamine, ce qui indique que le ciblage des enzymes de cette voie telle que l'enzyme malique pourrait être une approche prometteuse combinée à l'inhibition de l'enzyme de glutaminase. D'autre part, nous avons observé que mimant une hypoxie par des cellules de cancer du sein de traitement redirigée oligomycine pour augmenter la carboxylation réductrice. Considérant que l'hypoxie est une condition commune dans l'environnement de la tumeur, le ciblage mécanisme de carboxylation réductrice pourrait être une nouvelle stratégie de lutte contre le cancer. Collectivement, les résultats présentés dans cette thèse démontre l'importance du métabolisme de la prolifération des cellules cancéreuses et la survie. Ce travail met également en évidence l'importance de la biologie des systèmes se rapproche de comprendre les mécanismes moléculaires sous-jacents des maladies multifactorielles complexes afin de souligner de nouvelles cibles thérapeutiques potentielles. / Moreover, we characterized the metabolic adaptations that breast cancer cells undergo in the deprivation of glutamine or when mitochondria are defected. We conducted metabolic flux analysis using metabolomics and fluxomics approaches and we employed Systems Biology approaches in order to estimate a global view of flux alterations in different culture conditions. We observed an increased pyruvate cycle with glutamine deprivation, thus indicating that targeting the enzymes of this pathway such as malic enzyme could be a promising approach combined with inhibition of glutaminase enzyme. On the other hand, we observed that mimicking hypoxia by oligomycin treatment redirected breast cancer cells to increase reductive carboxylation. Considering that hypoxia is a common condition in the tumor environment, targeting reductive carboxylation mechanism could be a novel strategy to fight against cancer. Collectively, all the results provided in this thesis demosntrate the importance of metabolism in cancer cell proliferation and survival. This work also highlights the importance of Systems Biology approaches to comprehend the molecular mechanisms underlying complex multifactorial diseases in order to point out new potential therapeutic targets.

The female genital tract is a mucosal epithelium that has an array of factors contributing to the cervicovaginal immune environment. Like with systemic immunity, innate and adaptive immune mediators are integrated in the efficiency for fighting infections in the female genital tract. Our study addresses the role of pregnancy and HIV infection on concentrations of cytokines in genital tract fluid that play a role in HIV sexual transmission. We focused on two pathways: The NF-KB inflammation pathway that has been implicated in susceptibility to HIV infection, and two interferon pathways that have been associated with antiviral immune defense. We hypothesized that pregnant women have increased proinflammatory cytokines in genital secretions, potentially putting them at increased risk for HIV infection, and that HIV-infected women could have upregulated Type 1 interferon pathways that may regulate HIV replication in the genital tract, and infection by other viruses. This study compared the immune mediator profiles in genital secretions of women between the ages of 18 and 40 years old belonging to four groups: HIV Negative/ Non Pregnant, HIV Negative/Pregnant, HIV Positive/ Non Pregnant, and HIV positive/ pregnant. Cytokine concentrations in cervicovaginal lavage fluid were measured using ELISA and MAGPIX assays. A number of statistical methods were used to characterize cytokine pathways and to link pathway associated cytokines to HIV serostatus and/or pregnancy. The study showed that HIV positive women had higher levels of proinflammatory cytokines including IL-1α, IL-2RA, IL-4, IL-5, IL-6, IL-7, IL-12, IL-17, MIF, MIG, MIP-1ß, SCGF, TNF-α, and TRAIL. Only the antimicrobial peptide lysozyme was significantly decreased in HIV positive women. However, lysozyme was significantly increased in pregnant women where as the following cytokines were significantly decreased in pregnant women: ß-NGF, G-CSF, GM-CSF, GRO-α, HGF, IGN-α2, IFN-γ, IL-2RA, IL-3, IL-4, IL-6, IL-7, IL-12, IL-13, IL-16, IL-17, TNF-α, TRAIL. The correlation analysis showed that HIV positive nonpregnant women could have upregulated: NFκB, type I interferon and interferon-γ pathways. The correlation analysis showed that the NFκB pathway could be upregulated in pregnant HIV negative women and these findings suggest that vaginal inflammation may play a role in HIV transmission from HIV-infected women to uninfected pregnant women. Moreover, upregulated interferon pathways could help understand how the body regulates genital viral infections in HIV-infected women.

La spermatogenèse est le processus par lequel les cellules germinales se différencient pour former les spermatozoides. Elle se déroule à l’intérieur des tubes séminifères. Pendant la période embryonnaire, les précurseurs des cellules germinales adultes constituent un pool de cellules appelées cellules germinales primordiales (Primordial Germ Cells, PGCs), qui vont migrer pour aller coloniser les gonades (Durcova-Hills and Capel, 2008; Surani et al., 2008). Au cours de leur migration, les PGCs vont subir une reprogrammation épigénétique de l’ensemble de leur génome, qui leur sera nécessaire pour passer de l’état somatique à l’état de totipotence (Ohinata et al., 2005). Durant cette reprogrammation, l’ADN est massivement démethylé, entrainant l’activation de plusieurs gènes qui sont importants pour le développement des PGCs, mais également l’activation des éléments transposables (ETs) (Hajkova et al., 2008; Sasaki and Matsui, 2008; Surani and Hajkova, 2010). Ces derniers constituent environ 50% du génome des mammifères. Ils sont subdivisés en deux classes et sont connus par leur capacité à être mobilisés dans le génome (Zamudio and Bourc'his, 2010). Cette mobilisation se fait au hasard et constitue ainsi un risque considérable de mutations, qui peuvent provoquer des tumeurs, des pathologies de développement et une infertilité (Zamudio and Bourc'his, 2010). Pour cela, leur expression doit être contrôlée pour maintenir l’intégrité du génome de la lignée germinale. Pour toutes ces raisons, les PGCs ainsi que les cellules germinales en cours de méiose ont développé des stratégies de défenses pour contrôler la mobilisation et l’expression des ETs basées entre autre sur la voie des piwi-interacting RNA (piRNA) (Chuma and Pillai, 2009; Pillai and Chuma, 2012b). Dans le laboratoire du Pr. Stéphane Viville, mes travaux de thèse se sont concentrés sur l’étude d’un gène nommé Tex19 pour Testis Expressed gene chez la souris. Nous avons démontré que ce gène est spécifique des mammifères et est dupliqué chez le rat et la souris en deux paralogues nommés Tex19.1 et Tex19.2. Deux domaines hautement conservés ont été identifiés par alignement multiple des protéines TEX19 et nommés MCP et VPTEL. Ces domaines ne présentent aucune homologie avec des domaines déjà caractérisés, prévenant ainsi toute prédiction de leurs fonctions (Kuntz et al., 2008). L’étude du profil d’expression de Tex19.1 et Tex19.2 a montré que ces deux gènes sont exprimés dans l’ectoderme et les PGCs. Ils sont aussi co-exprimés dans le testicule de l’âge embryonnaire à l’âge adulte. Néanmoins, seul Tex19.1 est exprimé dans les ovaires et le précurseur du placenta appelé cône ectoplacentaire (Celebi et al., 2012). Le knockout (KO) de Tex19.1 provoque une infertilité masculine chez la souris avec un arrêt de la spermatogenèse au stade pachytène, accompagnée d’une surexpression d’un rétrotransposon, MMERVK10C (Ollinger et al., 2008). Récemment, il a été démontré que Tex19.1 joue aussi un rôle dans le développement du placenta (Reichmann et al., 2013). Au cours de mes trois années de thèse, nous avons approfondie l’étude du KO de Tex19.1dans le testicule, les cellules embryonnaires souches (Embryonic Stem Cells, ESCs) et le placenta (Tarabay et al., 2013). Nous avons également étudié le phénotype observé suite au double KO de Tex19.1 et Tex19.2. [...] / We recently characterized two new mammalian specific genes, Tex19.1 and its paralog Tex19.2. Both genes are expressed in pachytene spermatocytes in adult testes. In addition, Tex19.1 is expressed in pluripotent cells (ES, EG, iPS and PGC cells), the inner cell mass of the blastocysts and the placenta. In order to decipher Tex19 functions, we generate three types of knockout (KO): i) KO of Tex19.1 ii) KO of Tex19.2 iii) double KO (DKO) of both genes. All Tex19.1-/- KO animals are growth-retarded and half of them die just after birth. This phenotype is probably linked to placenta defects. Surviving adults Tex19.1-/- KO males display a variable spermatogenesis phenotype, associated with an up-regulation of one endogenous retrovirus, MMERVK10C. Tex19.2 KO mice exhibit a subtle phenotype. Few seminiferous epitheliums are degenerated while the rest appear normal. DKO show a fully penetrant phenotype similar to the most severe Tex19.1-/- phenotype. DKO males exhibit small testes. Despite the presence of spermatogonia and spermatocytes, spermatogenesis is blocked at the pachytene stage. By RNA deep-sequencing on 10 days old DKO and WT testes, prior to histological phenotype, 114 genes are significantly up-regulated and 320 genes significantly down-regulated in the DKO compared to the WT. Gene ontology analyses show that among of these genes, two essential pathways are altered: meiosis and the piRNA pathway. Consistent with that, GST-pulldown and immunoprecipitation experiments demonstrate that MIWI, MILI, MAEL and MVH are partners of TEX19. Considering PIWI proteins function in the silencing of transposable elements through the piRNA pathway, we checked if TEX19 paralogs bind piRNA. By immunoprecipitation using WT and KO testes, we show that both TEX19.1 and TEX19.2 bind small RNA of 30 nucleotides through their VPTEL domain. This study highlights the pivot role of Tex19 paralogs in three essential functions of mammalian life cycle, i.e. pluripotency, placenta-supported in utero growth and fertility. The functional similarities of both paralogs, through the expression control of one endogenous retrovirus and the binding of piRNAs, lead us to propose that Tex19 paralogs are new members of the piRNA pathway.

The aim of the thesis is to investigate the feasibility of using text mining methods to reconstruct patient journeys from unstructured clinical narratives. A novel method to extract and represent patient journeys is proposed and evaluated in this thesis. A composition of methods were designed, developed and evaluated to this end; which included health-related concept extraction, temporal information extraction, and concept clustering and automated work-flow generation. A suite of methods to extract clinical information from healthcare narratives were proposed and evaluated in order to enable chronological ordering of clinical concepts. Specifically, we proposed and evaluated a data-driven method to identify key clinical events (i.e., medical problems, treatments, and tests) using a sequence labelling algorithm, CRF, with a combination of lexical and syntactic features, and a rule-based post-processing method including label correction, boundary adjustment and false positive filter. The method was evaluated as part of the 2012 i2b2 challengeand achieved a state-of-the-art performance with a strict and lenient micro F1-measure of 83.45% and 91.13% respectively. A method to extract temporal expressions using a hybrid knowledge- (dictionary and rules) and data-driven (CRF) has been proposed and evaluated. The method demonstrated the state-of-the-art performance at the 2012 i2b2 challenge: F1-measure of 90.48% and accuracy of 70.44% for identification and normalisation respectively. For temporal ordering of events we proposed and evaluated a knowledge-driven method, with a F1-measure of 62.96% (considering the reduced temporal graph) or 70.22% for extraction of temporal links. The method developed consisted of initial rule-based identification and classification components which utilised contextual lexico-syntactic cues for inter-sentence links, string similarity for co-reference links, and subsequently a temporal closure component to calculate transitive relations of the extracted links. In a case study of survivors of childhood central nervous system tumours (medulloblastoma), qualitative evaluation showed that we were able to capture specific trends part of patient journeys. An overall quantitative evaluation score (average precision and recall) of 94-100% for individual and 97% for aggregated patient journeys were also achieved. Hence, indicating that text mining methods can be used to identify, extract and temporally organise key clinical concepts that make up a patient’s journey. We also presented an analyses of healthcare narratives, specifically exploring the content of clinical and patient narratives by using methods developed to extract patient journeys. We found that health-related quality of life concepts are more common in patient narrative, while clinical concepts (e.g., medical problems, treatments, tests) are more prevalent in clinical narratives. In addition, while both aggregated sets of narratives contain all investigated concepts; clinical narratives contain, proportionally, more health-related quality of life concepts than clinical concepts found in patient narratives. These results demonstrate that automated concept extraction, in particular health-related quality of life, as part of standard clinical practice is feasible. The proposed method presented herein demonstrated that text mining methods can be efficiently used to identify, extract and temporally organise key clinical concepts that make up a patient’s journey in a healthcare system. Automated reconstruction of patient journeys can potentially be of value for clinical practitioners and researchers, to aid large scale analyses of implemented care pathways, and subsequently help monitor, compare, develop and adjust clinical guidelines both in the areas of chronic diseases where there is plenty of data and rare conditions where potentially there are no established guidelines.

Atypical hemolytic uremic syndrome (aHUS) is a rare renal disorder characterized by thrombotic microangiopathy, thrombocytopenia, and acute kidney injury. Its pathogenesis has been attributed to a ‘triggering' event that leads to dysregulation of the complement cascade at the level of the endothelial cell surface. Consistent with this understanding of the disease, mutations in complement genes have been definitively implicated in aHUS. However, the existence of other genetic contributors is supported by two observations. First, in ~50% of cases, disease-causing variants are not identified in complement genes, and second, disease penetrance is typically incomplete and highly variable. To test this hypothesis, we identified pathways established to have crosstalk with the complement cascade, focusing initially on the coagulation pathway. Using targeted genomic enrichment and massively parallel sequencing we screened 36 European-American patients with sporadic aHUS patients for genetic variants in 85 complement and coagulation genes, identifying deleterious rare variants in several coagulation genes. The most frequently mutated coagulation gene in our study cohort was PLG, which encodes a zymogen of plasmin and plays key role in fibrinolysis. These results implicate the coagulation pathway in the pathogenesis of aHUS. Based on this outcome, we developed a clinical genetic testing panel to screen disease-related genes in a group of ultra-rare complement-mediated diseases that includes, in addition to aHUS, thrombotic thrombocytopenic purpura (TTP), C3 glomerulonephritis (C3GN) and dense deposit disease (DDD) patients. Data from 193 patients validate the usage of this panel in clinical practice and also provide confirmatory insight into the pathogeneses of these diseases. Specifically, we found that in aHUS and TTP patients, variants were frequently identified in complement regulator genes, while in C3GN and DDD patients, variants were additionally found in C3 convertase genes. To understand variability in disease penetrance, we completed targeted genetic screening in two aHUS families grossly discordant for disease penetrance, identifying in one family a co-segregating Factor X-deficiency variant (F10 p.Glu142Lys) that abrogated the effect of the complement mutation. Functional studies of the F10 p.Glu142Lys variant show that it decreases Factor X activity predicting to a hypo-coagulable state and further illustrating the importance of complement-coagulation crosstalk in exacerbating, but also mitigating the aHUS phenotype. In our final studies, we have sought to complete a comprehensive analysis for other potentially related pathways by using bioinformatics to identify candidate pathways coupled with whole exome sequencing. Preliminary data from 43 aHUS patients and 300 controls suggest that pathways for dermatan and heparan sulfate synthesis, which are relevant to the formation of the extra-cellular matrix and cell surface adhesion, may be implicated in the aHUS.

京都大学 / 0048 / 新制・課程博士 / 博士(理学) / 甲第22283号 / 理博第4597号 / 新制||理||1659(附属図書館) / 京都大学大学院理学研究科生物科学専攻 / (主査)准教授 佐藤 ゆたか, 教授 高橋 淑子, 准教授 秋山 秋梅 / 学位規則第4条第1項該当 / Doctor of Science / Kyoto University / DGAM

Lithium, a drug used for the treatment of bipolar disorder, has been shown to affect different aspects of neuronal development such as neuritogenesis, neurogenesis and survival. The underlying mechanism responsible for lithium's influence on neuronal development, however, still remains to be elucidated. In the present study, we demonstrate that lithium increases the phosphorylation of extracellular-signal regulated kinases (ERKs) and protein kinase B (Akt) and promotes neurite outgrowth in mouse N2a neuroblastoma cells (N2a). The inactivation of mitogen-activated protein kinase kinase (MEK)/ERKs signaling with a MEK inhibitor inhibits neurite outgrowth, but it enhances Akt activation in lithium-treated N2a cells. Furthermore, the inactivation of phosphoinositide-3-kinase (PI3K)/Akt signaling with a PI3K inhibitor increases both lithium-induced ERKs activation and lithium-induced neurite outgrowth. Taken together, our study suggests that lithium-induced neurite outgrowth in N2a cells is regulated by cross-talk between the MEK/ERKs and PI3K/Akt pathways and requires the activation of the MEK/ERKs signaling.